companydata.dkcompanydata.dk

PHARMADVICE ApS: Financial statements 2020

CVR: 26527651

Source: annual report 2020, Danish Business Authority

01/01/202031/12/2020

PHARMADVICE ApS (CVR 26527651) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 4,205,149 and a net result of DKK 309,150 compared with DKK -28,272 the year before. That is a decrease of 7.6% compared with the year before. Equity in the 2020 report amounted to DKK 1,013,373. The solvency ratio was 40.9%. The company had 5 employees in the financial year.

Gross Profit
DKK 4,205,149
Profit/Loss
DKK 309,150
Equity
DKK 1,013,373
Total Assets
DKK 2,479,977
Employees
5

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-4.2 mio.309 t.1 mio.5
2019-4.6 mio.-28 t.704 t.7
2018-3.8 mio.-55 t.832 t.6
2017-4.6 mio.-62 t.948 t.6
2016-5.9 mio.896 t.1.9 mio.5

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is PHARMADVICE ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

PHARMADVICE ApS: The 2019 annual report is outApr 20, 2020

PHARMADVICE ApS has published its annual report for 2019. Gross profit came to DKK 4,553,137, and the net result was DKK -28,272.

About PHARMADVICE ApS

PHARMADVICE ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2002. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Susanne Ølsgaard Felumb. The company is owned by Felumb Holding ApS. The company has 7 employees (2018). In 2025, the company reported a gross profit of DKK 6,375,693 and a net result of DKK 503,512 compared with DKK 658,935 the year before. Equity in the 2025 report amounted to DKK 1,402,268.

Source: annual report 2025, Danish Business Authority